We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+0.54%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$126B
AUM Growth
+$2.34B
Cap. Flow
+$2.62B
Cap. Flow %
2.07%
Top 10 Hldgs %
21.09%
Holding
8,008
New
182
Increased
3,096
Reduced
3,760
Closed
268

Sector Composition

Rank Sector Weight
1 Technology 6.16%
2 Financials 5.29%
3 Healthcare 5.26%
4 Consumer Discretionary 4.52%
5 Communication Services 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSTX
7201
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$5K ﹤0.01%
391
-1,093
-74% -$18K
STON
7202
CALL
DELISTED
StoneMor Inc.
STON
$5K ﹤0.01%
+4,500
New +$6.88K
ALNA
7203
DELISTED
Allena Pharmaceuticals
ALNA
$5K ﹤0.01%
1,307
-1,821
-58% -$7.82K
SBBP
7204
DELISTED
Strongbridge Biopharma plc.
SBBP
$5K ﹤0.01%
2,333
-8,168
-78% -$21.9K
CNST
7205
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$5K ﹤0.01%
843
-3,446
-80% -$28.8K
PRVL
7206
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$5K ﹤0.01%
+387
New +$4.38K
BQH
7207
DELISTED
BlackRock New York Municipal Bond Trust
BQH
$5K ﹤0.01%
350
DNI
7208
DELISTED
Dividend and Income Fund
DNI
$5K ﹤0.01%
400
DLBR
7209
DELISTED
VelocityShares Short LIBOR ETN
DLBR
0
FOMX
7210
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$5K ﹤0.01%
1,605
+340
+27% +$956
HOS
7211
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$5K ﹤0.01%
7,200
+3,000
+71% +$2.6K
ELGX
7212
DELISTED
Endologix Inc
ELGX
$5K ﹤0.01%
1,185
-3,990
-77% -$23.2K
ADRE
7213
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
$5K ﹤0.01%
125
NYNY
7214
DELISTED
Empire Resorts, Inc.
NYNY
$5K ﹤0.01%
567
-453
-44% -$4.36K
CTIC
7215
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$5K ﹤0.01%
5,784
-1,950
-25% -$1.49K
AVNW icon
7216
Aviat Networks
AVNW
$265M
$4K ﹤0.01%
600
AVTX icon
7217
Avalo Therapeutics
AVTX
$1.03B
-2
Closed -$22.3K
CHN
7218
DELISTED
China Fund
CHN
$4K ﹤0.01%
207
DALN
7219
DELISTED
DallasNews
DALN
$4K ﹤0.01%
286
FRAF icon
7220
Franklin Financial Services
FRAF
$284M
$4K ﹤0.01%
104
-1,980
-95% -$69.6K
FRI icon
7221
First Trust S&P REIT Index Fund
FRI
$194M
$4K ﹤0.01%
150
-200
-57% -$5.16K
GBDC icon
7222
Golub Capital BDC
GBDC
$3.36B
$4K ﹤0.01%
228
IAE
7223
Voya Asia Pacific High Dividend Equity Income Fund
IAE
$90.5M
$4K ﹤0.01%
500
IBRX icon
7224
ImmunityBio
IBRX
$7.32B
$4K ﹤0.01%
3,180
-1,068
-25% -$1.32K
IMAX icon
7225
CALL
IMAX
IMAX
$2.47B
$4K ﹤0.01%
200
+100
+100% +$2.12K

Similar funds

Citigroup's Q3 2019 Portfolio in Review

As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
  • Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
  • Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
  • Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
  • Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
  • Citigroup opened 182 new positions and closed 268 in Q3 2019.
  • Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.

Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.